Published: 7 March 2018
Author(s): Antonietta Gigante, Viviana Zingaretti, Marco Proietti, Edoardo Rosato, Rosario Cianci, HRV Study Group
Issue: March 2018
Section: Letter to the Editor

Atherosclerotic renal artery stenosis (ARAS) is a secondary cause of hypertension, with prevalence ranging from 1% to 5% in hypertensive patients. ARAS is associated with ischemic nephropathy, congestive heart failure and accelerated cardiovascular disease [1]. Autonomic dysfunction is a renowned risk factor for cardiovascular disease and several studies have documented that inflammation could play a crucial role between autonomic system and atherosclerosis [2]. The aim of the study is to evaluate if markers of increased cardiovascular risk, as autonomic dysfunction and QTc interval prolongation, can be detected in ARAS patients.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.